{"transactions":[{"id":4627094,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":19139,"kind":"person","name":"Ciongoli Gregory Austin","position":1,"cik":"0002023732","reported_name":"Ciongoli Gregory Austin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-25T21:01:11.000Z","date":"2026-09-23","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Corporation on each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":10.99,"expiration_date":"2036-09-22","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001628280-26-063616","document":"wk-form4_1790370069.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023732/000162828026063616/wk-form4_1790370069.xml","form_type":"4"}},{"id":673969,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":19139,"kind":"person","name":"Ciongoli Gregory Austin","position":1,"cik":"0002023732","reported_name":"Ciongoli Gregory Austin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2026-08-27T23:03:38.000Z","date":"2026-08-25","kind":"grant","planned":false,"acquired":true,"shares":69609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option will vest over a three year period, with 1/3rd of the option vesting on August 25, 2027 and the remaining portion of the option vesting in equal monthly installments over the 24 months thereafter, while the optionee provides continuous service to the Issuer."}],"balance_after":69609,"derivative":{"exercise_price":8.91,"exercise_date":"2027-08-25","expiration_date":"2036-08-25","underlying":"Common Stock","underlying_shares":69609},"source":{"system":"sec-edgar","filing":"0002023732-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2023732/000202373226000008/primarydocument.xml","form_type":"4"}},{"id":673968,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":19139,"kind":"person","name":"Ciongoli Gregory Austin","position":1,"cik":"0002023732","reported_name":"Ciongoli Gregory Austin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-27T23:03:38.000Z","date":"2026-08-27","kind":"purchase","planned":false,"acquired":true,"shares":53407,"price":9.356,"value":499675.892,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares purchased in an open-market transaction. The price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $9.17 to $9.4525. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":118035,"source":{"system":"sec-edgar","filing":"0002023732-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2023732/000202373226000008/primarydocument.xml","form_type":"4"}},{"id":673967,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":19139,"kind":"person","name":"Ciongoli Gregory Austin","position":1,"cik":"0002023732","reported_name":"Ciongoli Gregory Austin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-27T23:03:38.000Z","date":"2026-08-26","kind":"purchase","planned":false,"acquired":true,"shares":49196,"price":9.1411,"value":449705.5556,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares purchased in an open-market transaction. The price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $8.67 to $9.35. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":64628,"source":{"system":"sec-edgar","filing":"0002023732-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2023732/000202373226000008/primarydocument.xml","form_type":"4"}},{"id":673966,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":19139,"kind":"person","name":"Ciongoli Gregory Austin","position":1,"cik":"0002023732","reported_name":"Ciongoli Gregory Austin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-27T23:03:38.000Z","date":"2026-08-25","kind":"grant","planned":false,"acquired":true,"shares":15432,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU).  1/3rd of the shares subject to the RSU award shall vest on each of August 25, 2027, August 25, 2028 and August 25, 2029, while the recipient provides continuous service to the Issuer."}],"balance_after":15432,"source":{"system":"sec-edgar","filing":"0002023732-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023732/000202373226000008/primarydocument.xml","form_type":"4"}},{"id":741993,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19139,"kind":"person","name":"Ciongoli Gregory Austin","position":1,"cik":"0002023732","reported_name":"Ciongoli Gregory Austin","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2026-06-11T20:36:04.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units shall vest on the earlier of June 9, 2027 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0000905148-26-002919","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023732/000090514826002919/form4.xml","form_type":"4"}},{"id":941195,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":19139,"kind":"person","name":"Ciongoli Gregory Austin","position":1,"cik":"0002023732","reported_name":"Ciongoli Gregory Austin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-01-13T01:59:38.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":7700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting of the RSU, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs vest on January 12, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs vest on January 12, 2027."}],"balance_after":7700,"derivative":{"exercise_date":"2027-01-12","expiration_date":"2027-01-12","underlying":"Common Stock","underlying_shares":7700},"source":{"system":"sec-edgar","filing":"0001193125-26-010864","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2023732/000119312526010864/ownership.xml","form_type":"4"}},{"id":941194,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":19139,"kind":"person","name":"Ciongoli Gregory Austin","position":1,"cik":"0002023732","reported_name":"Ciongoli Gregory Austin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-13T01:59:38.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on January 12, 2027."}],"balance_after":11500,"derivative":{"exercise_price":23.16,"exercise_date":"2027-01-12","expiration_date":"2036-01-11","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001193125-26-010864","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023732/000119312526010864/ownership.xml","form_type":"4"}},{"id":1069099,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":19139,"kind":"person","name":"Ciongoli Gregory Austin","position":1,"cik":"0002023732","reported_name":"Ciongoli Gregory Austin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-13T00:30:06.000Z","date":"2025-08-11","kind":"grant","planned":false,"acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest in 36 equal monthly installments starting one month after grant date of August 11, 2025."}],"balance_after":62000,"derivative":{"exercise_price":12.44,"expiration_date":"2035-08-10","underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0000950170-25-107544","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2023732/000095017025107544/ownership.xml","form_type":"4"}},{"id":1069098,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":19139,"kind":"person","name":"Ciongoli Gregory Austin","position":1,"cik":"0002023732","reported_name":"Ciongoli Gregory Austin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-13T00:30:06.000Z","date":"2025-08-12","kind":"grant","planned":false,"acquired":true,"shares":415000,"price":12.02,"value":4988300.0,"ownership":{"direct":true},"balance_after":488500,"source":{"system":"sec-edgar","filing":"0000950170-25-107544","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023732/000095017025107544/ownership.xml","form_type":"4"}},{"id":1145774,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":79690,"kind":"person","name":"Adiumentum Capital Fund I LP","position":1,"cik":"0002023734","reported_name":"Adiumentum Capital Fund I LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See remarks"}},{"id":79691,"kind":"person","name":"Adiumentum Capital Fund I GP LLC","position":2,"cik":"0002023736","reported_name":"Adiumentum Capital Fund I GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See remarks"}},{"id":19139,"kind":"person","name":"Ciongoli Gregory Austin","position":3,"cik":"0002023732","reported_name":"Ciongoli Gregory Austin","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See remarks"}}],"security":"Warrants (right to buy)","published_at":"2025-05-16T22:26:21.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":227000,"price":6.6099,"value":1500447.3,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrants are immediately exercisable and do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrants are immediately exercisable and do not expire."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Pursuant to the terms of the warrants, the Issuer may not effect any exercise of any warrant, and a holder of a warrant does not have the right to exercise any portion of the warrant held by such holder, to the extent that, after giving effect to the attempted exercise set forth in a notice of exercise, such holder, together with such holder's affiliates and any other person whose beneficial ownership of common stock, par value $0.0001 per share (the \"Common Stock\"), of the Issuer would be aggregated with such holder's for the purposes of Section 13(d) of the Exchange Act, and the applicable regulations of the U.S. Securities and Exchange Commission (the \"SEC\"), including any \"group\" of which such holder is a member, would beneficially own a number of shares of Common Stock in excess of the Beneficial Ownership Limitation."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"The \"Beneficial Ownership Limitation\" is 19.99% of the shares of Common Stock then issued and outstanding, which percentage may be changed at a holder's election upon 61 days' notice to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Pursuant to the terms of the warrants, the Issuer may not effect any exercise of any warrant, and a holder of a warrant does not have the right to exercise any portion of the warrant held by such holder, to the extent that, after giving effect to the attempted exercise set forth in a notice of exercise, such holder, together with such holder's affiliates and any other person whose beneficial ownership of common stock, par value $0.0001 per share (the \"Common Stock\"), of the Issuer would be aggregated with such holder's for the purposes of Section 13(d) of the Exchange Act, and the applicable regulations of the U.S. Securities and Exchange Commission (the \"SEC\"), including any \"group\" of which such holder is a member, would beneficially own a number of shares of Common Stock in excess of the Beneficial Ownership Limitation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The \"Beneficial Ownership Limitation\" is 19.99% of the shares of Common Stock then issued and outstanding, which percentage may be changed at a holder's election upon 61 days' notice to the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"In addition to Adiumentum Capital Fund I LP, a limited partnership organized under the laws of Delaware (\"Adiumentum\"), this Form 4 is being filed jointly by Adiumentum Capital Fund I GP LLC, a limited liability company organized under the laws of Delaware and the general partner of Adiumentum (\"Adiumentum GP\"), and Gregory A. Ciongoli, a citizen of the United States of America and the managing member of Adiumentum GP (together with Adiumentum and Adiumentum GP, the \"Reporting Persons\"). Each of the Reporting Persons has the same business address as Adiumentum and may be deemed to have a pecuniary interest in securities reported on this Form 4 (the \"Subject Securities\"). Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Adiumentum may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) all of the Subject Securities. Adiumentum GP, as the general partner of Adiumentum may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) all the Subject Securities. Mr. Ciongoli, as the managing partner of Adiumentum, and as the managing member of Adiumentum GP, may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) all the Subject Securities."}],"balance_after":377193,"derivative":{"exercise_price":0.0001,"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001104659-25-050116","document":"tm2515303-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2023732/000110465925050116/tm2515303-1_4seq1.xml","form_type":"4"}},{"id":1145773,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":79690,"kind":"person","name":"Adiumentum Capital Fund I LP","position":1,"cik":"0002023734","reported_name":"Adiumentum Capital Fund I LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See remarks"}},{"id":79691,"kind":"person","name":"Adiumentum Capital Fund I GP LLC","position":2,"cik":"0002023736","reported_name":"Adiumentum Capital Fund I GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See remarks"}},{"id":19139,"kind":"person","name":"Ciongoli Gregory Austin","position":3,"cik":"0002023732","reported_name":"Ciongoli Gregory Austin","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2025-05-16T22:26:21.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":75572,"price":6.61,"value":499530.92,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"In addition to Adiumentum Capital Fund I LP, a limited partnership organized under the laws of Delaware (\"Adiumentum\"), this Form 4 is being filed jointly by Adiumentum Capital Fund I GP LLC, a limited liability company organized under the laws of Delaware and the general partner of Adiumentum (\"Adiumentum GP\"), and Gregory A. Ciongoli, a citizen of the United States of America and the managing member of Adiumentum GP (together with Adiumentum and Adiumentum GP, the \"Reporting Persons\"). Each of the Reporting Persons has the same business address as Adiumentum and may be deemed to have a pecuniary interest in securities reported on this Form 4 (the \"Subject Securities\"). Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Adiumentum may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) all of the Subject Securities. Adiumentum GP, as the general partner of Adiumentum may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) all the Subject Securities. Mr. Ciongoli, as the managing partner of Adiumentum, and as the managing member of Adiumentum GP, may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) all the Subject Securities."}],"balance_after":1209395,"source":{"system":"sec-edgar","filing":"0001104659-25-050116","document":"tm2515303-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023732/000110465925050116/tm2515303-1_4seq1.xml","form_type":"4"}}]}